What is the row between Wes Streeting and pharmaceutical companies about?

The article discusses the ongoing dispute between Wes Streeting, the UK's health secretary, and pharmaceutical companies over the pricing of drugs supplied to the National Health Service (NHS). The key points are: - The two sides have failed to reach an agreement on the financial terms for the provision of drugs to the NHS. - Streeting has accused pharmaceutical companies of being "shortsighted" and undermining their relationships with the government. - The failure to reach an agreement threatens to disrupt the supply of vital drugs to the NHS. - The row highlights the ongoing tensions between the government's efforts to control healthcare costs and the profit motives of pharmaceutical firms. The article provides a concise summary of the issue, focusing on the main facts and key points of contention between the two parties involved. It remains unbiased and avoids making any editorial judgments on the merits of the respective positions.